Advertisement Sutura settles patent infringement litigation with Abbott - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sutura settles patent infringement litigation with Abbott

US-based medical device company Sutura has settled a patent infringement lawsuit with Abbott Laboratories.

The settlement provides for a cross license of the Hathaway patents, licensed to Abbott by Indiana University, and the Sutura Nobles patents. In addition, Abbott has agreed to pay Sutura $23 million as part of the settlement agreement.

David Teckman, president and CEO of Sutura, said: “We now look forward to moving on with our continued enhancement of Sutura’s product line of vascular suturing devices, in particular the Sutura EL device.”